Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(633/week)
Manufacturing
(426/week)
Energy
(356/week)
Technology
(446/week)
Other Manufacturing
(359/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Axicabtagene ciloleucel
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Jan 28, 2020
2019 CAR-T Cell Therapy Market Study: Current Status, Patent Landscape, Funding, Deals, Research, Applications, Technologies, Marketed Products, Ongoing & Late Stage Clinical Trials
Oct 03, 2018
Japan MHLW Grants Orphan Drug Designation to Axicabtagene Ciloleucel for Treatment of Certain Types of B-Cell Lymphoma
Jul 30, 2018
Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dec 10, 2017
New Data for FDA-Approved CAR T Therapy Show Significant Remission Rates in 42% of Non-Hodgkin Lymphoma Patients
Dec 08, 2017
Seattle Cancer Care Alliance Selected as Authorized Treatment Center for Yescarta(TM) - A Novel, New Immunotherapy Treatment
Dec 04, 2017
Moffitt Cancer Center Treats First U.S. Patient with Newly FDA-Approved CAR-T Therapy
Oct 19, 2017
BioLife Solutions Customer Kite Pharma Receives FDA Approval for Yescarta(TM) (Axicabtagene Ciloleucel) CAR T-Cell Therapy
Oct 18, 2017
FDA Approves Second LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment
Oct 18, 2017
FDA Approves Yescarta(TM), Revolutionary CAR-T Immunotherapy for Non-Hodgkin's Lymphoma Patients
Oct 18, 2017
FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma
Sep 05, 2017
Cryoport Selected to Support the Potential Commercial Launch of Kite Pharma's CAR-T Therapy Axicabtagene Ciloleucel
Jun 24, 2017
European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive non-Hodgkin Lymphoma (NHL)
Latest News
May 10, 2024
GeoPark Signs New Offtake Agreement With Vitol for the Llanos 34 Block in Colombia
May 10, 2024
California American Water Proudly Recognizes American Water Charitable Foundation 2024 Water and Environment...
May 10, 2024
Cameco Announces Election of Directors
May 10, 2024
SIFCO Industries, Inc. (“SIFCO”) Announces Second Quarter Fiscal 2024 Financial Results
May 10, 2024
Suzano announces first quarter results and Cerrado Project nears completion
May 10, 2024
NextDecade Provides First Quarter 2024 Business Update
May 10, 2024
Sherritt Announces Voting Results of its 2024 Annual Meeting of Shareholders
May 10, 2024
Pembina Pipeline Corporation Reports Strong Results for the First Quarter 2024 and Raises Quarterly Common...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events